Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery
- Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome
- Pacific Biosciences? Recent Advances with its Sequel SMRT? Technology, Combined with Illumina?s Infrastructure, will Expand Biological Discovery and Clinical Insight
- Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022
View source version on businesswire.com: https://www.businesswire.com/news/home/20181101006099/en/
Source: Illumina, Inc. Illumina, Inc. Media Contacts Jen Carroll (858) 449-8082 pr@illumina.com OR Investors: Jacquie Ross, CFA (858) 882-2172 ir@illumina.com